chr1-156868568-T-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_002529.4(NTRK1):āc.638T>Cā(p.Leu213Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000122 in 1,554,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L213L) has been classified as Likely benign.
Frequency
Consequence
NM_002529.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NTRK1 | NM_002529.4 | c.638T>C | p.Leu213Pro | missense_variant | 6/17 | ENST00000524377.7 | |
NTRK1 | NM_001012331.2 | c.638T>C | p.Leu213Pro | missense_variant | 6/16 | ||
NTRK1 | NM_001007792.1 | c.548T>C | p.Leu183Pro | missense_variant | 7/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NTRK1 | ENST00000524377.7 | c.638T>C | p.Leu213Pro | missense_variant | 6/17 | 1 | NM_002529.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152050Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000121 AC: 17AN: 1402856Hom.: 0 Cov.: 33 AF XY: 0.0000159 AC XY: 11AN XY: 692302
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152050Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74266
ClinVar
Submissions by phenotype
Hereditary insensitivity to pain with anhidrosis Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 18, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 213 of the NTRK1 protein (p.Leu213Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal recessive congenital insensitivity to pain with anhidrosis (PMID: 10330344, 12949319). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 526734). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NTRK1 protein function. Experimental studies have shown that this missense change affects NTRK1 function (PMID: 11159935, 11719521, 27551041). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 25, 2021 | - - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The p.L213P variant (also known as c.638T>C), located in coding exon 6 of the NTRK1 gene, results from a T to C substitution at nucleotide position 638. The leucine at codon 213 is replaced by proline, an amino acid with similar properties. This alteration was detected in trans with truncating mutations in NTRK1 in two unrelated individuals (Mardy S et al. Am J Hum Genet, 1999 Jun;64:1570-9; Bonkowsky JL et al. Pediatrics, 2003 Sep;112:e237-41). Functional studies indicate that this alteration results in abnormal localization and loss of activation of the NTRK1 protein (Franco ML et al. J Biol Chem, 2016 Oct;291:21363-21374; Mardy S et al. Hum Mol Genet, 2001 Feb;10:179-88; Miranda C et al. J Biol Chem, 2002 Feb;277:6455-62). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at